Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization
β Scribed by G. Colella; R. Bottelli; L. De Carlis; C. V. Sansalone; G. F. Rondinara; A. Alberti; L. S. Belli; F. Gelosa; G. M. Iamoni; A. Rampoldi; A. De Gasperi; A. Corti; E. Mazza; P. Aseni; A. Meroni; A. O. Slim; M. Finzi; F. Di Benedetto; F. Manochehri; M. L. Follini; G. Ideo; D. Forti
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 149 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Supraselective transarterial chemoembolization (STACE) more efficiently targets chemotherapy delivered via the feeding arterial branches of the tumor than does conventional transarterial chemoembolization (TACE). However, the hypothesis of its greater efficacy compared with the latter is subject to
For "early" hepatocellular carcinoma (HCC), surgery, orthotopic liver transplantation (OLT) and percutaneous ethanol injection (PEI) improve the natural history of the disease. We performed a retrospective study to evaluate the outcome of patients with cirrhosis and early HCC treated by PEI (n = 417
Current selection criteria of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) were derived from the outcomes of cadaveric donor LT (CDLT). We tried to assess the applicability of such criteria to living donor LT (LDLT) through a comparative study between CDLT and LDLT. We